- AI in PV
- AI Implementation
- AI Training
- AI Compliance
- Regional Coverage
- Expertise
- QPPV Services
- Medical Safety
- Aggregate Reports
- Signal and Risk Management
- Audits and Due Diligence
- Training and Consultancy
- Digital Transformation
- Technology
Find out about the latest developments and changes happening at iVigee here.
Audio Recap, Click Here. Gambia updated its Guideline for Clinical Trials in Humans, effective February 26. This change impacts multiple regulatory areas including aggregate safety reports, clinical trials, and post-marketing ICSR reporting. iViReg users received the validated alert on March 3, with full updates reflected in the Gambia Country Profile by March 10.
Sign up to receive free alerts just like these!
iVigee 2023 milestones. We 2019ve had a few!
As 2023 draws to a close, it a good time to review some of iVigee 2019 s key successes and look back over what has been a tremendous year of innovation and growth for us, captured in this post 2019s slideshow.
Complexity and Priorities - Explaining AI in Pharmacovigilance.
Understanding the relevance of AI and Large Language Models (LLMs) like GPT-4 within pharmacovigilance can be difficult, but the key is to demystify their complexity and prioritize explanation.
Whatever your pharmacovigilance requirements, our world-leading technology platforms and globally experienced operational teams can provide the solution.